Muta T, Masamoto Y, Yamamoto G, Kurahashi S, et al. Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study. Int J Hematol 2024 Nov 26. doi: 10.1007/s12185-024-03875.
PMID: 39586984